Received Aug 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Shingles after 1st dose of Shingrix; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles after 1st dose of Shingrix). The outcome of the shingles was not reported. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK receipt date: 18-AUG-2025 This case was reported by a patient via interactive digital media. The reporter reported that one vaccine had worked, while the other had caused people to develop shingles. The reporter reported that his/her mother had gotten shingles from one vaccine but not the other. The effective vaccine was called Shingrix.; Sender's Comments: GSK-US2025AMR107265:Case for other vaccine